- Home
- NRXP vs NOM Comparison
NRXP vs NOM Comparison
Compare NRXP & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- NOM
- Stock Information
- Founded
- NRXP 2015
- NOM 1993
- Country
- NRXP United States
- NOM United States
- Employees
- NRXP N/A
- NOM N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- NOM Investment Managers
- Sector
- NRXP Health Care
- NOM Finance
- Exchange
- NRXP Nasdaq
- NOM Nasdaq
- Market Cap
- NRXP 34.7M
- NOM 28.0M
- IPO Year
- NRXP N/A
- NOM N/A
- Fundamental
- Price
- NRXP $2.01
- NOM $10.46
- Analyst Decision
- NRXP Strong Buy
- NOM
- Analyst Count
- NRXP 4
- NOM 0
- Target Price
- NRXP $28.25
- NOM N/A
- AVG Volume (30 Days)
- NRXP 185.3K
- NOM 6.9K
- Earning Date
- NRXP 05-13-2025
- NOM 01-01-0001
- Dividend Yield
- NRXP N/A
- NOM 3.39%
- EPS Growth
- NRXP N/A
- NOM N/A
- EPS
- NRXP N/A
- NOM N/A
- Revenue
- NRXP N/A
- NOM N/A
- Revenue This Year
- NRXP N/A
- NOM N/A
- Revenue Next Year
- NRXP N/A
- NOM N/A
- P/E Ratio
- NRXP N/A
- NOM N/A
- Revenue Growth
- NRXP N/A
- NOM N/A
- 52 Week Low
- NRXP $1.10
- NOM $8.52
- 52 Week High
- NRXP $6.01
- NOM $10.48
- Technical
- Relative Strength Index (RSI)
- NRXP 42.26
- NOM 42.10
- Support Level
- NRXP $1.95
- NOM $10.39
- Resistance Level
- NRXP $2.12
- NOM $10.59
- Average True Range (ATR)
- NRXP 0.18
- NOM 0.09
- MACD
- NRXP 0.01
- NOM 0.02
- Stochastic Oscillator
- NRXP 23.08
- NOM 62.83
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in United States. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Missouri state income taxes; its secondary investment objective is the enhancement of portfolio value. The fund invests in municipal securities as well as floating rate securities as well as derivatives such as futures, options and swap contracts to the necessary extent. Nuveen Fund Advisors, LLC acts as an investment adviser of the company.